4//SEC Filing
REGENERON PHARMACEUTICALS INC 4
Accession 0001237899-14-000020
$REGNCIK 0000872589operating
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 7:38 PM ET
Size
23.9 KB
Accession
0001237899-14-000020
Insider Transaction Report
Form 4
SHOOTER ERIC M
Director
Transactions
- Exercise/Conversion
Common Stock
2014-02-12$57.11/sh+5,000$285,550→ 10,000 total - Exercise/Conversion
Common Stock
2014-02-12$177.82/sh+5,000$889,100→ 5,000 total - Exercise/Conversion
Common Stock
2014-02-12$33.42/sh+5,000$167,100→ 15,000 total - Sale
Common Stock
2014-02-12$320.41/sh−12,878$4,126,240→ 2,122 total - Sale
Common Stock
2014-02-12$321.22/sh−2,122$681,629→ 0 total - Conversion
Common Stock
2014-02-12+7,000→ 7,000 total(indirect: By Trust) - Gift
Common Stock
2014-02-12−7,000→ 0 total(indirect: By Trust) - Conversion
Class A Stock
2014-02-12−7,000→ 85 total(indirect: By Trust)→ Common Stock (7,000 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2014-02-12−5,000→ 0 totalExercise: $33.42Exp: 2021-01-03→ Common Stock (5,000 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2014-02-12−5,000→ 5,000 totalExercise: $57.11Exp: 2022-01-03→ Common Stock (5,000 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2014-02-12−5,000→ 10,000 totalExercise: $177.82Exp: 2023-01-02→ Common Stock (5,000 underlying)
Holdings
- 2,500(indirect: GRAT self)
Common Stock
- 2,500(indirect: By Spouse)
Common Stock
Footnotes (7)
- [F1]Represents volume-weighted average price of sales of 12,878 shares of Company stock on February 12, 2014 at prices ranging from $320.00 to $320.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 12, 2014 at each separate price.
- [F2]Represents volume-weighted average price of sales of 2,122 shares of Company stock on February 12, 2014 at prices ranging from $321.00 to $321.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 12, 2014 at each separate price.
- [F3]Gift of Common Stock to a charitable foundation.
- [F4]Class A Stock of Regeneron Pharmaceuticals, Inc. ("Regeneron") converts to Common Stock of Regeneron on a one-to-one basis upon certain events or upon election of the shareholder.
- [F5]Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
- [F6]Shares of Class A Stock are convertible at any time on a share-for-share basis into Common Stock.
- [F7]The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS INC
CIK 0000872589
Entity typeoperating
IncorporatedNY
Related Parties
1- filerCIK 0000872589
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 7:38 PM ET
- Size
- 23.9 KB